-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, F5jJc9cSZsr2XQS/B5GRg4nr2qDCaDpqtjw9PUIBc4qDTST7sYx62tgO7QUO9DtC pfTRl7qcH2uJTBIHgu8cHg== 0000950153-04-000390.txt : 20040217 0000950153-04-000390.hdr.sgml : 20040216 20040217114921 ACCESSION NUMBER: 0000950153-04-000390 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20040217 GROUP MEMBERS: CARNEGIE BANK A/S GROUP MEMBERS: CARNEGIE GLOBAL HEALTHCARE FUND MANAGEMENT COMPANY S.A. GROUP MEMBERS: CARNEGIE KAPITALFORVALTNING AB GROUP MEMBERS: D CARNEGIE & CO. AB FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BANQUE CARNEGIE LUXEMBOURGH S A CENTRAL INDEX KEY: 0001208218 IRS NUMBER: 000000000 STATE OF INCORPORATION: G7 FILING VALUES: FORM TYPE: SC 13G MAIL ADDRESS: STREET 1: CENTRE EUROPE STREET 2: 5 PLACE DE LA GARE L 1616 CITY: LUXEMBOURG STATE: N4 ZIP: 999999999 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SONIC INNOVATIONS INC CENTRAL INDEX KEY: 0001105982 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 870494518 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-60749 FILM NUMBER: 04605315 BUSINESS ADDRESS: STREET 1: 2795 EAST COTTONWOOD PARKWAY, SUITE 660 STREET 2: SUITE 660 CITY: SALT LAKE CITY STATE: UT ZIP: 84117-7261 BUSINESS PHONE: 8013652800 MAIL ADDRESS: STREET 1: 2795 EAST COTTOMOOD PARKWAY STREET 2: SUITE 660 CITY: SALT LAKE CITY STATE: UT ZIP: 84117-7261 SC 13G 1 p68803bsc13g.htm SC 13G sc13g
Table of Contents

OMB APPROVAL
OMB Number: 3235-0145
Expires: December 31, 2005
Estimated average burden
hours per response...11


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No.        )*

Sonic Innovations, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

83545M109

(Cusip Number)

August 31, 2001

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

        x Rule 13d-1 (b)

        o Rule 13d-1 (c)

        o Rule 13d-1 (d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the notes).

 

Table of Contents

             
13G
CUSIP No. 83545M109 Page 2 of 11
  1. Name of Reporting Person:
Banque Carnegie Luxembourg S.A. 		I.R.S. Identification Nos. of above persons (entities only):
  2. Check the Appropriate Box if a Member of a Group:
    (a) x  
    (b) o  
  3. SEC Use Only:
  4. Citizenship or Place of Organization:
Luxembourg
Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
5. Sole Voting Power:
6. Shared Voting Power:
861,607
7. Sole Dispositive Power:
8.Shared Dispositive Power:
861,607
  9.Aggregate Amount Beneficially Owned by Each Reporting Person:
861,607
  10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares:
o
  11.Percent of Class Represented by Amount in Row (9):
4.3%
  12.Type of Reporting Person:
HC/BK

Table of Contents

             
13G
CUSIP No. Page of
  1. Name of Reporting Person:
Carnegie Global Healthcare Fund Management Company S.A. 		I.R.S. Identification Nos. of above persons (entities only):
  2. Check the Appropriate Box if a Member of a Group:
    (a) x  
    (b) o  
  3. SEC Use Only:
  4. Citizenship or Place of Organization:
Luxembourg
Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
5. Sole Voting Power:
6. Shared Voting Power:
861,607
7. Sole Dispositive Power:
8.Shared Dispositive Power:
861,607
  9.Aggregate Amount Beneficially Owned by Each Reporting Person:
861,607
  10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares:
o
  11.Percent of Class Represented by Amount in Row (9):
4.3%
  12.Type of Reporting Person:
IV

Table of Contents

             
13G
CUSIP No. Page of
  1. Name of Reporting Person:
Carnegie Bank A/S 		I.R.S. Identification Nos. of above persons (entities only):
  2. Check the Appropriate Box if a Member of a Group:
    (a) x  
    (b) o  
  3. SEC Use Only:
  4. Citizenship or Place of Organization:
Denmark
Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
5. Sole Voting Power:
6. Shared Voting Power:
861,607
7. Sole Dispositive Power:
8.Shared Dispositive Power:
861,607
  9.Aggregate Amount Beneficially Owned by Each Reporting Person:
861,607
  10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares:
o
  11.Percent of Class Represented by Amount in Row (9):
4.3%
  12.Type of Reporting Person:
HC/BK

Table of Contents

             
13G
CUSIP No. Page of
  1. Name of Reporting Person:
D Carnegie & Co. AB 		I.R.S. Identification Nos. of above persons (entities only):
  2. Check the Appropriate Box if a Member of a Group:
    (a) x  
    (b) o  
  3. SEC Use Only:
  4. Citizenship or Place of Organization:
Sweden
Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
5. Sole Voting Power:
6. Shared Voting Power:
861,607
7. Sole Dispositive Power:
8.Shared Dispositive Power:
861,607
  9.Aggregate Amount Beneficially Owned by Each Reporting Person:
861,607
  10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares:
o
  11.Percent of Class Represented by Amount in Row (9):
4.3%
  12.Type of Reporting Person:
HC

Table of Contents

             
13G
CUSIP No. Page of
  1. Name of Reporting Person:
Carnegie Kapitalforvaltning AB 		I.R.S. Identification Nos. of above persons (entities only):
  2. Check the Appropriate Box if a Member of a Group:
    (a) x  
    (b) o  
  3. SEC Use Only:
  4. Citizenship or Place of Organization:
Sweden
Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
5. Sole Voting Power:
6. Shared Voting Power:
861,607
7. Sole Dispositive Power:
8.Shared Dispositive Power:
861,607
  9.Aggregate Amount Beneficially Owned by Each Reporting Person:
861,607
  10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares:
o
  11.Percent of Class Represented by Amount in Row (9):
4.3%
  12.Type of Reporting Person:
IA

Item 1(a). Name of Issuer
Item 1(b). Address of Issuer’s Principal Executive Offices
Item 2(a). Name of Person Filing
Item 2(b). Address of Principal Business Office or, if None, Residence
Item 2(c). Citizenship
Item 2(d). Title of Class of Securities
Item 2(e). CUSIP Number
Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b), check whether the person filing is a:
Item 4. Ownership
Item 5. Ownership of Five Percent or Less of a Class
Item 6. Ownership of More than Five Percent on Behalf of Another Person
Item 7. Identification and Classification of the Subsidiary Which acquired the Security Being Reported on by the Parent Holding Company
Item 8. Identification and Classification of Members of the Group
Item 9. Notice of Dissolution of Group
Item 10. Certification
SIGNATURE

Table of Contents

Item 1(a). Name of Issuer

The name of the issuer is Sonic Innovations, Inc.

Item 1(b). Address of Issuer’s Principal Executive Offices

The address of the issuer’s principal executive offices is 2795 East Cottonwood Parkway, Suite 660, Salt Lake City, Utah 84121-7036.

Item 2(a). Name of Person Filing

Banque Carnegie Luxembourg S.A.
Carnegie Global Healthcare Fund Management Company S.A.
Carnegie Bank A/S
D Carnegie & Co. AB
Carnegie Kapitalforvaltning AB

Item 2(b). Address of Principal Business Office or, if None, Residence

Banque Carnegie Luxembourg S.A.
Carnegie Global Healthcare Fund Management Company S.A.
Centre Europe
5, Place de la Gare
L-1616 Luxembourg
Grand-Duchy of Luxembourg

Carnegie Bank A/S
Overgaden neden Vandet 9B
DK-1023
Copenhagen K
Denmark

D Carnegie & Co AB
Vastra Tradgardsgatan 15
SE-103 38, Stockholm
Sweden

Carnegie Kapitalforvaltning AB
Vastra Tradgardsgatan 15
SE-103 38, Stockholm

Item 2(c). Citizenship

Banque Carnegie Luxembourg S.A. — Luxembourg
Carnegie Global Healthcare Fund Management Company S.A. — Luxembourg
Carnegie Bank A/S — Denmark

Page 7 of 11

Table of Contents

D Carnegie & Co. AB — Sweden
Carnegie Kapitalforvaltning AB — Sweden

Item 2(d). Title of Class of Securities

Common Stock

Item 2(e). CUSIP Number

83545M109

Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b), check whether the person filing is a:

Not applicable.

Item 4. Ownership

(a)   Amount beneficially owned by the group: 861,607.

    Each of Banque Carnegie Luxembourg S.A., Carnegie Bank A/S, D Carnegie & Co. AB, and Carnegie Kapitalforvaltning AB declares that the filing of this Schedule 13G shall not be construed as an admission that it is, for purposes of Section 13(d) of the Exchange Act or otherwise, the beneficial owner of any of the shares covered by this Schedule 13G, and they hereby disclaim beneficial ownership. Carnegie Global Healthcare Fund Management Company S.A. makes independent decisions through its Investment Manager, Carnegie Kapitalforvaltning AB.

(b)   Percent of class: 4.3%

(c)   Number of shares to which the person has:

  (i)   Sole power to vote or to direct the vote: 0

  (ii)   Shared power to vote or to direct the vote: 861,607

  (iii)   Sole power to dispose or to direct the disposition of: 0

  (iv)   Shared power to dispose or to direct the disposition of: 861,607

Item 5. Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: [x]

The reporting person became the beneficial owner of more than five percent of the class of securities on August 31, 2001, but since that time has ceased to be the beneficial owner of more than five percent of the class of securities.

Page 8 of 11

Table of Contents

Item 6. Ownership of More than Five Percent on Behalf of Another Person

Not applicable.

Item 7. Identification and Classification of the Subsidiary Which acquired the Security Being Reported on by the Parent Holding Company

Carnegie Global Healthcare Fund Management Company S.A. is a wholly owned subsidiary of Banque Carnegie Luxembourg S.A. Banque Carnegie Luxembourg S.A. is a wholly owned subsidiary of Carnegie Bank A/S, which in turn is a wholly owned subsidiary of D Carnegie & Co. AB. Carnegie Kapitalforvaltning AB is the Investment Manager for Carnegie Global Healthcare Fund Management Company S.A.

Item 8. Identification and Classification of Members of the Group

Carnegie Global Healthcare Fund Management Company S.A. is a wholly owned subsidiary of Banque Carnegie Luxembourg S.A. Banque Carnegie Luxembourg S.A. is a wholly owned subsidiary of Carnegie Bank A/S, which in turn is a wholly owned subsidiary of D Carnegie & Co. AB. Carnegie Kapitalforvaltning AB is the Investment Manager for Carnegie Global Healthcare Fund Management Company S.A.

Item 9. Notice of Dissolution of Group

Not applicable.

Item 10. Certification

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

Page 9 of 11

Table of Contents

SIGNATURE

     After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

         
Date: February 13, 2004        
         
    Banque Carnegie Luxembourg S.A.(1)
         
        /s/ W. T. Eggleston, Jr.
   
    Name:   W. T. Eggleston, Jr.
    Title:   Attorney-in-Fact

(1)   Pursuant to the Joint Filing Agreement attached hereto as Exhibit A among Carnegie Global Healthcare Fund Management Company S.A., Banque Carnegie Luxembourg S.A., Carnegie Bank A/S, D Carnegie & Co. AB, and Carnegie Kapitalforvaltning AB, this Schedule 13G is filed on behalf of each of them.

Page 10 of 11

Table of Contents

EXHIBIT A

JOINT FILING AGREEMENT

     In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the Common Stock of New Brunswick Scientific Co., Inc. and further agree to the filing of this agreement as an Exhibit thereto. In addition, each party to this Agreement expressly authorizes each other party to this Agreement to file on its behalf any and all amendments to such Statement on Schedule 13G.

         
Date: February 13, 2004        
         
    Banque Carnegie Luxembourg S.A.
         
        /s/ W. T. Eggleston, Jr.
   
    Name:   W. T. Eggleston, Jr.
    Title:   Attorney-in-Fact
         
    Carnegie Global Healthcare Fund Management Company S.A.
         
        /s/ W. T. Eggleston, Jr.
   
    Name:   W. T. Eggleston, Jr.
    Title:   Attorney-in-Fact
         
    Carnegie Kapitalforvaltning AB
         
        /s/ W. T. Eggleston, Jr.
   
    Name:   W. T. Eggleston, Jr.
    Title:   Attorney-in-Fact
         
    Carnegie Bank A/S
         
        /s/ W. T. Eggleston, Jr.
   
    Name:   W. T. Eggleston, Jr.
    Title:   Attorney-in-Fact
         
    D Carnegie & Co. AB
         
        /s/ W. T. Eggleston, Jr.
   
    Name:   W. T. Eggleston, Jr.
    Title:   Attorney-in-Fact

Page 11 of 11 -----END PRIVACY-ENHANCED MESSAGE-----